266 related articles for article (PubMed ID: 15931642)
1. Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration.
Buemi M; Floccari F; Crisafulli A; Cavallaro E; Ruello A; Caccamo C; Loddo S; Aloisi C; Corica F; Romeo A; Frisina N; Teti D
J Nephrol; 2005; 18(2):148-53. PubMed ID: 15931642
[TBL] [Abstract][Full Text] [Related]
2. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
[TBL] [Abstract][Full Text] [Related]
3. Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.
Kraj M; Owczarska K; Sokołowska U; Centkowski P; Pogłód R; Kruk B
Arch Immunol Ther Exp (Warsz); 2005; 53(5):454-64. PubMed ID: 16314829
[TBL] [Abstract][Full Text] [Related]
4. Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6.
Abrahamsen B; Stilgren LS; Rettmer E; Bonnevie-Nielsen V; Beck-Nielsen H
Calcif Tissue Int; 2003 Jan; 72(1):18-23. PubMed ID: 12384814
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment.
Mossetti G; Rendina D; De Filippo G; Viceconti R; Di Domenico G; Cioffi M; Postiglione L; Nunziata V
Bone; 2005 Mar; 36(3):549-54. PubMed ID: 15777635
[TBL] [Abstract][Full Text] [Related]
6. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
[TBL] [Abstract][Full Text] [Related]
8. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients.
Wiercinska-Drapalo A; Jaroszewicz J; Tarasow E; Flisiak R; Prokopowicz D
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):160-8. PubMed ID: 16303613
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture.
Lee JS; Ryu CH; Moon NH; Kim SJ; Park SY; Suh KT
Arch Orthop Trauma Surg; 2009 May; 129(5):711-8. PubMed ID: 18427820
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
[TBL] [Abstract][Full Text] [Related]
12. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity.
Kim SM; Lee J; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Clin Endocrinol (Oxf); 2005 Nov; 63(5):594-8. PubMed ID: 16268814
[TBL] [Abstract][Full Text] [Related]
13. Serum osteoprotegerin levels in healthy controls and cancer patients.
Lipton A; Ali SM; Leitzel K; Chinchilli V; Witters L; Engle L; Holloway D; Bekker P; Dunstan CR
Clin Cancer Res; 2002 Jul; 8(7):2306-10. PubMed ID: 12114435
[TBL] [Abstract][Full Text] [Related]
14. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
[TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro.
Penno H; Silfverswärd CJ; Frost A; Brändström H; Nilsson O; Ljunggren O
Biochem Biophys Res Commun; 2002 Apr; 293(1):451-5. PubMed ID: 12054622
[TBL] [Abstract][Full Text] [Related]
16. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
18. High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis.
Ishii R; Morimoto A; Ikushima S; Sugimoto T; Asami K; Bessho F; Kudo K; Tsunematu Y; Fujimoto J; Imashuku S
Pediatr Blood Cancer; 2006 Aug; 47(2):194-9. PubMed ID: 16358318
[TBL] [Abstract][Full Text] [Related]
19. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
[TBL] [Abstract][Full Text] [Related]
20. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
